- Home
- INTS vs SFHG Comparison
INTS vs SFHG Comparison
Compare INTS & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- SFHG
- Stock Information
- Founded
- INTS 2012
- SFHG 1993
- Country
- INTS United States
- SFHG Hong Kong
- Employees
- INTS N/A
- SFHG N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- SFHG Publishing
- Sector
- INTS Health Care
- SFHG Consumer Discretionary
- Exchange
- INTS Nasdaq
- SFHG Nasdaq
- Market Cap
- INTS 12.2M
- SFHG 11.7M
- IPO Year
- INTS 2023
- SFHG 2024
- Fundamental
- Price
- INTS $0.62
- SFHG $0.50
- Analyst Decision
- INTS Strong Buy
- SFHG
- Analyst Count
- INTS 4
- SFHG 0
- Target Price
- INTS $4.50
- SFHG N/A
- AVG Volume (30 Days)
- INTS 85.6M
- SFHG 58.2K
- Earning Date
- INTS 11-17-2025
- SFHG 10-30-2025
- Dividend Yield
- INTS N/A
- SFHG N/A
- EPS Growth
- INTS N/A
- SFHG N/A
- EPS
- INTS N/A
- SFHG N/A
- Revenue
- INTS N/A
- SFHG $19,577,200.00
- Revenue This Year
- INTS N/A
- SFHG N/A
- Revenue Next Year
- INTS N/A
- SFHG N/A
- P/E Ratio
- INTS N/A
- SFHG N/A
- Revenue Growth
- INTS N/A
- SFHG 3.56
- 52 Week Low
- INTS $0.19
- SFHG $0.49
- 52 Week High
- INTS $3.40
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- INTS 57.24
- SFHG 21.04
- Support Level
- INTS $0.23
- SFHG $0.58
- Resistance Level
- INTS $1.74
- SFHG $0.68
- Average True Range (ATR)
- INTS 0.14
- SFHG 0.03
- MACD
- INTS 0.06
- SFHG -0.00
- Stochastic Oscillator
- INTS 25.69
- SFHG 2.49
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.